Regional REIT adds eight offices to its portfolio Regional REIT (RGL) has announced that it has exchanged and completed on contracts to purchase eight assets for £31.4 million. (Update 24/08/2018) the acquisition was completed on 23rd August 2018. Regional diversification The portfolio is spread out from the Stockton-on-Tees in the North to High Wycombe in the South. […]
BlackRock Emerging Europe’s liquidation plans announced – on 14th June, the Board of BlackRock Emerging Europe (BEEP) announced that its tender offer had not secured enough money to make continuing running the company viable. Click here to read more on our coverage of that decision. The Board of BEEP have looked at the options and have come up with […]
HBM-backed Argenx has biotech industry’s most valuable unpartnered R&D asset Dutch/Belgian antibody company Argenx (Euronext & Nasdaq:ARGX), a top ten holding for Swiss-listed HBM Healthcare (HBMN, 2.9% of NAV), has the biotech industry’s most valuable unpartnered R&D asset in the form of its lead compound efgartigimod for myasthenia gravis and other autoimmune diseases, according to industry […]
WPCT avoids losses on Woodford-backed Abzena Woodford Investment Management will have to take a second painful hit on one of its major biotech investments in less than a week, after the UK-based drug discovery services company Abzena agreed to a low-ball private equity takeout today after seeing a sustained share price decline. This deal follows the […]
IBT adds to Celgene, reduces Neurocrine in July rejig International Biotechnology Trust (IBT) appears to have boosted its shareholding in Celgene – which has risen by one place and ~ two NAV percentage points to become its top investee company, as part of a rejig of its largest investments in July. According to the trust’s latest […]
Lazard World Trust Board responds to City of London letter – On 15th August, we reported that City of London Investment Management (CLIG), who run the investment trust City of London (CTY), has written a letter to the Directors of Lazard World Trust Fund (WTR) explaining its intention to oppose renewing the WTR’s buyback authority at the EGM to be held on […]
John Laing Environmental Assets acquires another anaerobic digestion plant – John Laing Environmental Assets (JLEN) has announced the acquisition of an anaerobic digestion (AD) asset, from Merlin Renewables Limited for a total consideration, including working capital, of c. £18.1 million. Location The Merlin AD plant is located in Hibaldstow, North Lincolnshire and was commissioned in September 2014. The […]
Stafford Capital responds to Phaunos’ defence document – on 14th August 2018, the Chairman of Phaunos Timber (PTF) sent a letter to Phaunos Shareholders, giving them an update on plans to wind up the company and to reject the cash offer made on 3rd July by Stafford Capital Partners. Click here to see a copy of the letter In […]
City of London writes to shareholders of Lazard World Trust – City of London Investment Management (CLIG), who run the investment trust City of London (CTY), has written a letter to the Directors of Lazard World Trust Fund (WTR) explaining its intention to oppose renewing the WTR’s buyback authority at the EGM to be held on 30 August, 2018. CLIG comments that […]
WPCT set to record £33m gain on Sensyne Health IPO Woodford Patient Capital Trust (WPCT) looks set to record a £33m gain and a 45x return on its original shareholding in the UK healthcare AI firm Sensyne Health, as a result of the company’s IPO on the London stock exchange. Sensyne, which was founded and […]
